Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use LACOSAMIDE ORAL SOLUTION safely and effectively. See full prescribing information for LACOSAMIDE ORAL SOLUTION. LACOSAMIDE oral solution, CV Initial U.S. Approval: 2008
Medication labelWhy this: Advisory · dailymed-prescription
Lacosamide is indicated for the treatment of partial-onset seizures in patients 4 year of age and older. Additional pediatric use information is approved for UCB, Inc.’s VIMPAT® (lacosamide) oral solution. However, due to UCB, Inc.’s marketing exclusivity rights, this drug product is not labeled with that information.
- generic_name
- lacosamide
- product_names
- Lacosamide
- ndc
- 0904-7463, 70954-488, 0904-7463-41, 0904-7463-68, 0904-7464, 0904-7464-66, 0904-7464-64
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en